Zobrazeno 1 - 10
of 176
pro vyhledávání: '"Ki-Hoon Han"'
Autor:
Dae-Geun Jin, Ki-Hoon Han
Publikováno v:
Journal of Coaching Development. 24:153-163
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::148b5cb938fa5d0784bca45f7d865d37
https://doi.org/10.47684/jcd.2022.11.24.5.153
https://doi.org/10.47684/jcd.2022.11.24.5.153
Autor:
Mi-Jung Kim, Ki-Hoon Han
Publikováno v:
Korean Journal of Security Convergence Management. 11:325-335
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6e42e7ecefcf28eb4569d5f6b147198a
https://doi.org/10.24826/kscs.11.11.20
https://doi.org/10.24826/kscs.11.11.20
Autor:
Han Saem, Jeong, Soon Jun, Hong, Jin-Man, Cho, Ki Hoon, Han, Dong-Hun, Cha, Sang-Ho, Jo, Hyun-Jae, Kang, So-Yeon, Choi, Cheol Ung, Choi, Eun Jeong, Cho, Young-Hoon, Jeong, Hyeon-Cheol, Gwon, Byeong-Keuk, Kim, Sung Yun, Lee, Sang-Hyun, Kim, Jeong Cheon, Ahn, Young Joon, Hong, Woo-Shik, Kim, Seong-Ill, Woo, Tae-Ho, Park, Kyoo-Rok, Han
Publikováno v:
Clinical Therapeutics. 44:1310-1325
Pitavastatin is a unique lipophilic statin with moderate efficacy in lowering LDL-C levels by 30% to 50% with a tolerable safety profile. However, the efficacy of adding ezetimibe to pitavastatin in patients with dyslipidemia has not been well invest
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f8967dbb11190fcf553697cdd6ae4c11
https://doi.org/10.1016/j.clinthera.2022.09.001
https://doi.org/10.1016/j.clinthera.2022.09.001
Autor:
Ki Hoon Han, Sung Hea Kim, Sang Hak Lee, Myung Soo Park, Jong-Chan Youn, Byung Jin Kim, Sung Uk Kwon, Eung Ju Kim, Kyu-Hyung Ryu
Publikováno v:
Clinical Therapeutics. 43:1735-1747
PURPOSE Residual cardiovascular risk reduction by fenofibrate in patients with high serum triglyceride (TG) levels despite previous statin monotherapy is not well characterized. The purpose of this study was to evaluate the efficacy and safety of a c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a3991008c8f0f333a94880d69067088d
https://doi.org/10.1016/j.clinthera.2021.08.005
https://doi.org/10.1016/j.clinthera.2021.08.005
Autor:
Seong-Wook Park, Seung-Jung Park, Do-Yoon Kang, Yong-Hoon Yoon, Pil Hyung Lee, Soo-Jin Kang, Ki Hoon Han, Seung-Whan Lee, Jung-Min Ahn, Cheol Whan Lee, Young-Hak Kim, Duk-Woo Park
Publikováno v:
JACC: Cardiovascular Interventions. 14:2059-2068
Objectives This study evaluated the association between elevated levels of lipoprotein(a) [Lp(a)] and risk of recurrent ischemic events in patients who underwent percutaneous coronary intervention (PCI). Background Elevated levels of Lp(a) have been
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::25c62ad0f85d501fc367a14a4f2a06e2
https://doi.org/10.1016/j.jcin.2021.07.042
https://doi.org/10.1016/j.jcin.2021.07.042
Autor:
Jae-Woong Kim, Ki Hoon Han
Publikováno v:
The Korean Journal of Physical Education. 60:535-543
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::03eea5d7ec72bb10b93c30c6836dddfb
https://doi.org/10.23949/kjpe.2021.1.60.1.38
https://doi.org/10.23949/kjpe.2021.1.60.1.38
Autor:
Hae Young Lee, Hyeon Cheol Gwon, Dong-Ju Choi, Pum Joon Kim, Woo Baek Chung, Seung-Woon Rha, Kyoo Rok Han, Si Wan Choi, Woo Shik Kim, Ki Hoon Han, Bum-Kee Hong, Kyung Tae Jung, Jei Keon Chae, Tae Ho Park, Eun-Seok Shin, Sung Ho Her, Myung Ho Jeong, So-Yeon Choi, Jong Min Lee, Jong Seon Park, Namsik Chung
Publikováno v:
Clinical Therapeutics. 42:2036-2048
Purpose Although the role of high-intensity lipid-lowering therapy in cardiovascular protection has broadened, concerns still exist about new-onset diabetes mellitus (NODM), especially in vulnerable patients. This study aimed to compare the effect of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::21d61b8ae04ba06d207495fb95da34cf
https://doi.org/10.1016/j.clinthera.2020.07.013
https://doi.org/10.1016/j.clinthera.2020.07.013
Autor:
Han Cheol Lee, Ki Chul Sung, Jinho Shin, Jin Man Cho, Moo Hyun Kim, Sang Hyun Lee, Ki Hoon Han, Xuan Jin, Hyungseop Kim, Hana Lee, Jeong Cheon Ahn, Kihwan Kwon, In Ho Chae, Pum Joon Kim, Jung Hoon Sung, Chang Gyu Park, Min Su Hyon, Jeong Sook Seo, Seung Pyo Hong, Moo Yong Rhee, Jae-Hwan Lee, Kyounghoon Lee, Byung Su Yoo, Woo Shik Kim, Yoonhwa Cho, So-Yeon Choi, Soon Jun Hong, Jin-Yong Hwang, Hyo-Soo Kim, Eun Joo Cho, Ju Han Kim
Publikováno v:
Journal of Clinical Hypertension (Greenwich, Conn.)
Single risk factors, such as hypertension and dyslipidemia, can combine to exacerbate the development and severity of cardiovascular disease. Treatment goals may be more effectively achieved if multiple disease factors are targeted with combination t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a9f9dab5c5efdeea3b72febd6d282c04
https://doi.org/10.1111/jch.13893
https://doi.org/10.1111/jch.13893
Publikováno v:
Annals of laboratory medicine. 43(1)
High LDL-cholesterol (LDL-C) is an established risk factor for cardiovascular disease and is considered an important therapeutic target. It can be measured directly or calculated from the results of other lipid tests. The Friedewald formula is the mo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::af998de1131852200a4d9d748894873d
https://pubmed.ncbi.nlm.nih.gov/36045054
https://pubmed.ncbi.nlm.nih.gov/36045054
Publikováno v:
Annals of Laboratory Medicine; 2023, Vol. 43 Issue 1, p29-37, 9p